Citation: De. Stull et al., Self-report quality of life as a predictor of hospitalization for patientswith LV dysfunction: A life course approach, RES NURS H, 24(6), 2001, pp. 460-469
Authors:
Spearman, P
Fiscus, SA
Smith, RM
Shepard, R
Johnson, B
Nicotera, J
Harris, VL
Clough, LA
McKinsey, J
Haass, DW
Citation: P. Spearman et al., Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid, J CLIN MICR, 39(4), 2001, pp. 1612-1614
Authors:
Haas, DW
Clough, LA
Johnson, BW
Harris, VL
Spearman, P
Wilkinson, GR
Fletcher, CV
Fiscus, S
Raffanti, S
Donlon, R
McKinsey, J
Nicotera, J
Schmidt, D
Shoup, RE
Kates, RE
Lloyd, RM
Larder, B
Citation: Dw. Haas et al., Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma, AIDS RES H, 16(15), 2000, pp. 1491-1502
Authors:
Haas, DW
Stone, J
Clough, LA
Johnson, B
Spearman, P
Harris, VL
Nicotera, J
Johnson, RH
Raffanti, S
Zhong, L
Bergqwist, P
Chamberlin, S
Hoagland, V
Ju, WD
Citation: Dw. Haas et al., Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection, CLIN PHARM, 68(4), 2000, pp. 367-374